Tag:

social media

Latest Headlines

Latest Headlines

Pfizer amps up its 'Get old' campaign with more content, more social media

What's #FOGO? Hint: Many of us have it. Another hint: Pfizer wants people to talk about it.

FDA garbles social media education, but social media discipline is clear enough

The FDA may be having problems handing down its social media commandments. But it's playing enforcer just the same.

In social media, what's easier to grasp--an FDA webinar or an FDA warning?

The FDA may be having problems handing down its social media commandments. But it's playing enforcer just the same.

The FDA should step up its own social-media action, NEJM researchers say

The FDA has given drugmakers some social media advice. Now, researchers have some online advice for the FDA.

Experts warn FDA Twitter guidance will silence social conversation

Having had a week to mull over the FDA's latest batch of social media guidance, some observers have concluded the agency is making a blunt statement to brand managers: Don't use Twitter.

FDA's social media translation for brand managers: Don't use Twitter

Any brand managers eager to jump into Twitter as soon as the FDA gave the go-ahead? No such luck. Last week's social media guidance on risk disclosures may have cleared up some of the regulatory fog, but in this case, clarity isn't a positive.

FDA speaks on social media: No benefits without risks, even on Twitter

The FDA has unveiled two more pieces of its social media guidance. 

Big Pharma sees danger, not safety, in FDA's new social media guidance

The FDA may have released its latest social media guidance in January, but judging by the industry's reaction, it appears some of pharma's marketers don't have any more answers than they did before. In fact, they have more questions.

Pfizer, PhRMA and others pick holes in FDA social media guidance

Drugmakers received the first slice of FDA social media guidance in January, and now the FDA's mailbag is filling up with letters on First Amendment protections, "jurisdictional creep" and other topics from the likes of Pfizer and PhRMA.

Pharma continues to grapple with trial participants' use of social media

While it is years now since clinical trial participants started talking about their experiences online, the industry is still searching for the best way to approach the phenomenon. And with pharma needing to improve the clinical trial process, the onus is on the industry to find systems that not only manage the negative implications of social media, but tap into its power, too.